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The functional consequences of the interaction of transcriptional coregulators with the human thyroid hormone
receptor (TR) in mammalian cells are complex.We have used the yeast, Saccharomyces cerevisiae, which
lack endogenous nuclear receptors (NRs) and NR coregulators, as a model to decipher mechanisms regulating
transcriptional activation by TR. In effect, this system allows the reconstitution of TR mediated transcription
complexes by the expression of specific combinations of mammalian proteins in yeast. In this yeast system,
human adenovirus 5 early region 1A (E1A), a natural N-CoR splice variant (N-CoRI) or an artificial N-CoR
truncation (N-CoRC) coactivate unliganded TRs and these effects are inhibited by thyroid hormone (TH). E1A
contains a short peptide sequence that resembles known corepressor-NR interaction motifs (CoRNR box
motif, CBM), and this motif is required for TR binding and coactivation. N-CoRI and N-CoRC contain three
CBMs, but only the C-terminal CBM1 is critical for coactivation.These observations in a yeast model system
suggest that E1A and N-CoRI are naturally occurring TR coactivators that bind in the typical corepressor
mode.These findings also raise the possibility that alternative splicing events which form corepressor proteins
containing only C-terminal CBM motifs could represent a novel mechanism in mammalian cells for regulating
constitutive transcriptional activation by TRs.
Received May 7th, 2006; Accepted September 1st, 2006; Published October 30th, 2006  | Abbreviations: CBM:CoRNR box motif; CoR:corepressor;
CoRNR:CoR-NR interaction; E1A:human adenovirus type 5 early region 1A; ID:interacting domain; N-CoR:NR corepressor; NR:nuclear receptor;
RD: repressor domain; SMRT: silencing mediator for retinoid receptors and TRs; TH:thyroid hormone; TR:TH receptor; TRE:TH response element;
TSH: thyroid-stimulating hormone | Copyright © 2006, Meng et al.This is an open-access article distributed under the terms of the Creative Commons
Non-Commercial Attribution License, which permits unrestricted non-commercial use distribution and reproduction in any medium, provided the original
work is properly cited.
Cite this article: Nuclear Receptor Signaling (2006) 4, e022
Exploitation of yeast as a model system
for studying gene regulation by nuclear
receptors
Nuclear receptor (NR) mediated gene activation or
repression is regulated by the cellular context of
transcriptional coactivators and corepressors (CoRs)
[Cheng, 2000; Glass and Rosenfeld, 2000; McKenna and
O'Malley, 2002]. Due to the complexity of endogenous
NR coregulators in mammalian cells it is difficult to
determine the precise mechanisms by which NR
coactivators and corepressors function.
The budding yeast Saccharomyces cerevisiae contains
the conserved eukaryotic general transcriptional
apparatus and chromatin remodeling enzymes, but is
devoid of nuclear receptors and their coregulators (see
[Anafi et al., 2000; Meng et al., 2003;Walfish et al., 1997]
and references therein). In this yeast model system it
becomes possible to measure qualitatively and
quantitatively the functions of exogenous cofactors by
reconstituting desired combinations of factors in isolation
from the bewildering effects of a myriad of endogenous
competing factors.
Transcriptional coactivation by factors
binding to unliganded NRs
Our previous studies have proved that two types of human
thyroid hormone receptor (hTR) coactivation pathways
can be reconstituted in the yeast Saccharomyces
cerevisiae. Firstly, p160 proteins, such as GRIP1 and
SRC1, which contain LXXLL motifs necessary for
hormone dependent interaction with the TR [Heery et al.,
1997;Torchia et al., 1997], require thyroid hormone (TH)
and the SAGA adaptor protein complex to function [Anafi
et al., 2000].This pathway is akin to TR coactivation
pathways that have been extensively studied in
mammalian systems [Cheng, 2000; Glass and Rosenfeld,
2000] and functions through the intrinsic acetyltransferase
activity of the SAGA adaptor complex [Anafi et al., 2000].
Secondly, human adenovirus type 5 early region 1A (E1A)
protein behaves as a TH independent TR coactivator in
yeast and does not require GCN5 or other components
of SAGA [Meng et al., 2003]. Interestingly, coactivation
of TR dependent transcription by E1A is lost upon addition
of hormone through a ligand induced loss of E1A-TR
interaction [Meng et al., 2003].
Hormone-dependent loss of E1A-TR interaction is
reminiscent of TR interactions with nuclear receptor
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Perspective  Nuclear Receptor Signaling  |  The Open Access Journal of the Nuclear Receptor Signaling AtlasFigure 1.  Analysis of the importance of the various CBMs for N-CoRC coactivation in hTR dependent gene activation in yeast Left Side:
A schematic depiction of the portions of N-CoRC used in this study, which were fused to the GAL4-DNA binding domain.The amino acid residues
present in each fragment are as indicated, as are the positions of the CBMs. Right Side: β-gal assays were performed with a yeast strain containing a
β-galactosidase reporter gene regulated by single copy of the chicken lysozyme (F2) TRE and expressing hTRβ1, the indicated portions of N-CoRC
or empty vector. Cultures were treated with either vehicle (grey bars) or 10
-6 M Triac (black bars). β-gal activity is expressed as Miller units per mg of
protein. Data shown were pooled from three independent experiments and calculated as mean ± SE. Assay conditions as described previously [Meng
et al., 2005;Walfish et al., 1997].
corepressors such as N-CoR and SMRT, which interact
with unliganded TR and with other NRs in the absence
of hormone or in the presence of antagonists [Cheng,
2000; Glass and Rosenfeld, 2000].The corepressors
contain NR interacting domains that share a core
consensus motif: ΦXXΦΦ (where Φ is a hydrophobic
residue and X is any amino acid) that comprise part of
the extended consensus LXXI/HIXXXI/L CoRNR box motif
(CBM) [Hu and Lazar, 1999].These motifs are believed
to encode an extended amphipathic helix which contacts
the same hydrophobic pocket that binds LXXLL motifs,
but is not dependent on the charge clamp and the AF2
helix [Hu and Lazar, 1999; Perissi et al., 1999].This
configuration has been confirmed in an X-ray crystal
structure of peroxisome proliferator activated receptor α
in complex with an antagonist and a SMRT CBM peptide
[Xu et al., 2002]. Inspection of E1A identified a short
sequence (LDQLIEEVL amino acids 20-28) that strongly
resembles a CBM and this was shown to be necessary
for TR binding and coactivation, and to bind the same TR
surface as corepressors [Meng et al., 2005; Meng et al.,
2003].Thus, a viral protein has co-opted a cellular protein
interaction motif to target the unliganded TR. Although
E1A binding to unliganded TR mimics that of
corepressors, the end result is to confer constitutive
coactivation function.
The interaction of E1A with TR in the absence of TH
exemplifies the economical nature of adenovirus E1A to
stoichometrically affect target protein function [Frisch and
Mymryk, 2002]. Clearly, if the purpose of the interaction
of E1A with the unliganded TR is to activate transcription,
there is no need for E1A to bind the TR in the presence
of hormone and duplicate the function of existing cellular
coactivators.This is highly reminiscent of the interaction
of E1A with pRb, which regulates exit from the G1 phase
of the cell cycle. In this case, E1A binds the
hypophosphorylated form of pRb, which is actively
involved in blocking G1 exit, but does not interact with
inactive hyperphosphorylated forms of pRb [Mittnacht et
al., 1994]. Presumably, the frugality of targeting only those
cellular proteins actively engaged in some activity
preserves adequate levels of unbound E1A to serve all
necessary cellular targets. However, the exact role of the
interaction of the E1A protein with the TR is not clear.
Inspection of the human adenovirus 5 genome failed to
identify any consensus direct repeat TREs, but a number
of consensus half sites are present. It remains to be
determined if the TR can function through these half sites
and whether the E1A proteins can influence any such
activity, but it is tempting to speculate that they may play
a role in controlling viral transcription and or replication
in some fashion.
Given similarities between nuclear hormone receptors, it
is also possible that E1A could engage in functionally
important interactions with corepressor binding domains
of other members of this family of transcription factors.
Nevertheless, there is precedent for a role of thyroid
hormone in regulating viral life cycle, as simian virus 40,
human immunodeficiency virus type 1 and herpes simplex
virus all contain functional TREs that control viral gene
transcription [Desai-Yajnik et al., 1995; Desvergne and
Favez, 1997; Park et al., 1993; Zuo et al., 1997].
These studies on the viral E1A protein also culminated
in the novel observation that a nuclear receptor
corepressor splice variant (N-CoRI) or a C-terminal
fragment of N-CoR (N-CoRC) also act as hTR coactivators
that bind in the repressor mode [Meng et al., 2005]. Both
N-CoRI and N-CoRC lack the autonomous N-terminal
repression domain found in the well characterized full
length form of N-CoR. In the absence of the N-terminal
domain, a paradoxical constitutive coactivation function
can be observed which is dependent upon binding to hTR
in a corepressor mode [Meng et al., 2005].
Mechanism of ligand independent
transcriptional activation of NRs
N-CoRI/N-CoRC or E1A thus act as novel constitutive
coactivators (CCs) through the interaction of their CBMs
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Although, this mechanism appears entirely different from
that of TH dependent coactivators (DCs), such as GRIP1
or SRC1 [Anafi et al., 2000; Meng et al., 2003], both types
of coactivators nevertheless enhance transcription of their
target genes.To further explore the mechanisms by which
N-CoRI/N-CoRC function as activators, we constructed
deletion mutants and determined that CBM1 is much
more important than CBM2 and CBM3 for coactivation
(Figure 1). If CBM1 was deleted, more than 90% of
activity was lost.We also determined that CBM1 contains
an intrinsic activation function using yeast one hybrid
analysis (data not shown). Future studies will delimit the
boundaries of this activation function and identify its
target.
Although full-length N-CoR (FL-N-CoR) acts as a TR
corepressor, N-CoRI/N-CoRC function as coactivators
that bind and activate unliganded TR in a yeast
coexpression system.This likely occurs because these
splice variants of N-CoR lack the intrinsic N-CoR
repressor domain and harbor a hitherto unrecognized
coactivator function that lies in the vicinity of CBM1.When
a p160 coactivator is coexpressed in a yeast model
system [Anafi et al., 2000;Walfish et al., 1997] or is
endogenously present in a mammalian cell, TH induces
hormone dependent coactivation (DC; Figure 2, left
panel). In contrast, when a p160 coactivator is either not
present or expressed at a relatively low level, TH induces
a hormone dependent repression (i.e. negative regulation)
on the constitutive unliganded coactivation of N-CoRI
(CC; Figure 2, right panel).
Figure 2.  Schematic model in yeast of transcriptional regulation
by corepressor or coactivator regulators  Left Side:The transcriptional
response of FL-N-CoR and a p160 coactivator in the absence and
presence of TH. Addition of TH leads to hormone dependent coactivation
(DC). Right Side:The constitutive coactivation (CC) of a natural splice
variant N-CoRI in the absence and presence of TH.
It must be acknowledged that experimental evidence for
the physiological relevance of ligand independent
activation by N-CoRI in mammalian cells is lacking.
However, splice variants devoid of N-terminal repressor
domains have been isolated in mammalian cells for
N-CoRI [Hollenberg et al., 1996] as well as s-SMRT [Chen
and Evans, 1995; Ordentlich et al., 1999] and TRAC-1
[Sande and Privalsky, 1996]. Moreover, these splice
variants have been observed to not only be devoid of
repressor function but may also have a dominant-negative
inhibitory effect on corepressor function [Chen and Evans,
1995; Hollenberg et al., 1996; Sande and Privalsky, 1996]
and thereby serve as “anti-corepressors”.Thus, it remains
a possibility that ratio differences in the cellular context
of corepressor FL compared to their splice variants may
result in either an overall anti-corepressor or perhaps a
predominant coactivator influence on TR regulated genes.
Intriguingly, there is increasing recognition that splice
variants of N-CoR and SMRT corepressors may be
adapted and tailored by alternative mRNA splicing to
different cells and to different developmental stages as
a mechanism for regulating metazoan gene expression
(see [Goodson et al., 2005a] and references therein).
Moreover, differences in the expression of corepressors
in different tissues and at various times of development
suggest that organisms may adapt to their corepressor
repertoire for distinct biological purposes [Jepsen et al.,
2000]. Since a number of alternatively spliced variants
have been shown to differ in their abundance at different
times of development or in different tissues [Goodson et
al., 2005b; Malartre et al., 2004; Short et al., 2005], further
studies will be required to fully understand the biological
properties of such sequences. It is likely that modules
within N-CoR and SMRT regulate the repression or
activation of target genes by recruiting domain specific
transcriptional regulators (see [Goodson et al., 2005a]
and references therein). Although the characterization of
such regulators is still in its infancy, alternative splicing
events could represent a mechanism by which cells can
modulate varying degrees of corepression or coactivation
of target genes.
It is possible that there are other mechanisms which could
alter the ratio of full-length corepressors and their splice
variants in mammalian cells. FL-N-CoR is targeted for
proteasomal degradation by interaction with the mSiah2
ubiquitin ligase, which binds the N-terminal 160 amino
acid residues [Zhang et al., 1998]. As this N-terminal
region is absent in N-CoRI, mSiah2 should preferentially
degrade FL-N-CoR.This could alter the ratio of FL-N-CoR
to N-CoRI and potentially influence gene expression.
mSiah2 expression is known to be cell-type specific
[Zhang et al., 1998]. Interestingly, estrogen up-regulates
mSiah2 expression leading to the subsequent degradation
of FL-N-CoR [Frasor et al., 2005], suggesting the
presence of a complex feedback pathway that could come
into play under certain conditions. Future studies should
focus on the identification and characterization of genes
essential for CC or DC mediated gene activation by NRs.
It is likely that some of these genes will play a role in
regulating CoR function, whether by affecting their
transcription, splicing, degradation or post-translational
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